RxDoctor Payments Data

Benjamin Windham, APRN

Family · Batesville, MSNPI 1104478932

Payments from drug & device makers

$600in general payments, 2019–2025

Across 34 payments — averaging $17.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$226
  • Novo Nordisk$102
  • Pfizer$70
  • Amgen$44
  • GSK$40
  • Lilly USA, LLC$31
  • plus $88 from 5 others

What the payments were for

  • Food & beverage$600100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$600 in reported general payments places this provider in the 55th percentile of 3,007 family providers in Mississippi.

See all family providers in Mississippi

Medicare billing

Part B allowed, 2024
$22,579
Medicare patients
171
Services billed
193

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst26$313
Ibuprofen19$68
Ondansetron Hcl12$46

Paid to pharmacies, not to this prescriber.

Other family in Batesville

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →